METex14 ctDNA Dynamics & Resistance Mechanisms Detected in Liquid Biopsy (LBx) From Patients (pts) With METex14 Skipping NSCLC Treated With Tepotinib
作者:
Paik, P. [1]
;
O'Hara, R. [2]
;
Veillon, R. [3]
;
Felip, E. [4]
;
Cortot, A. [5]
;
Sakai, H. [6]
;
Mazieres, J. [7]
;
Thomas, M. [8]
;
Reinmuth, N. [9]
;
Raskin, J. [10]
;
Conte, P. [11]
;
Garassino, M. [12]
;
Iams, W. T. [13]
;
Griesinger, F. [14]
;
Kowalski, D. [15]
;
Stroh, C. [16]
;
Juraeva, D. [17]
;
Scheuenpflug, J. [18]
;
Johne, A. [19]
;
Le, X. [20]
作者单位:
Dept Thorac Oncol,Asklepios Clin Munich Gauting
[1]
Dept Pulmonol & Thorac Oncol,Antwerp Univ Hosp UZA
[2]
Thoraxklin,Heidelberg Univ
[3]
Translat Med,Healthcare Business Merck KGaA
[4]
Serv Malad Resp,CHU Bordeaux
[5]
Dept Lung Canc & Thorac Oncol,Maria Sklodowska Curie Natl Res Inst Oncol
[6]
Translat Innovat Platform,Healthcare Business Merck KGaA
[7]
Weill Cornell Med Coll
[8]
Inst Univ Canc,CHU Toulouse
[9]
Dept Oncol,Vall dHebron Inst Oncol VHIO
[10]
Dept Thorac Head & Neck Med Oncol,Univ Texas MD Anderson Canc Ctr
[11]
Thorac Oncol Serv,Mem Sloan Kettering Canc Ctr
[12]
Dept Med Oncol,Fdn IRCCS Ist Nazl Tumori
[13]
Dept Hematol & Oncol,Univ Med Oldenburg
[14]
Dept Surg Oncol & Gastroenterol,Univ Padua
[15]
Clin Biomarkers & Compan Diagnost,Healthcare Business Merck KGaA
[16]
CHU Lille,Univ Lille
[17]
Dept Thorac Oncol,Saitama Canc Ctr
[18]
Med Ctr,Vanderbilt Univ
[19]
Global Clin Dev,Healthcare Business Merck KGaA
[20]
发布时间
2022-04-29
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文